分子育种市场－全球产业规模、份额、趋势、机会、预测：按标记、应用、製程、地区和竞争对手划分，2021-2031年

全球分子育种市场预计将从 2025 年的 77.9 亿美元成长到 2031 年的 123.7 亿美元，年复合成长率为 8.01%。

该领域专注于利用分子生物学技术，特别是DNA标记，在不进行基因工程的情况下，鑑定具有特定遗传优势（例如抗病性或增产）的动植物。由于无需等待表型发育即可鑑定基因，因此该方法显着加快了育种进程。市场的主要驱动因素是全球对高品质食品供应日益增长的需求以及对耐气候变迁作物的迫切需求。这并非暂时的市场趋势，而是农业永续性的根本性和长期性要求。

然而，各国复杂且分散的监管体系阻碍了这一市场扩张。育种技术政策的差异造成了巨大的合规障碍，可能延缓改良品种的市场准入。国际种子联盟2024年的数据凸显了这一问题，约75%的种子产业专家警告称，不一致或不科学的监管规定威胁着该产业保障全球粮食安全的能力。此类监管方面的不确定性会阻碍遗传物质的国际交流，为研究资金筹措带来挑战，并减缓分子育种技术进步的传播。

市场驱动因素

CRISPR-Cas9 和先进基因编辑工具的引入正在改变全球分子育种市场，使无需引入外源 DNA 即可进行精准的基因修饰成为可能。这项技术进步使育种者能够比传统方法更快地培育出高产量、耐候性强的作物，有效省去了以往漫长的回交阶段。法规环境对这些技术的接受度日益提高，基因编辑作物与传统育种作物的分类也越来越趋于一致。这降低了合规成本和进入门槛。根据 Euroseeds 统计，截至 2024 年底，全球已有约 300 项监管决定批准将「新基因组技术 (NGT) 植物」核准传统分类，预计到 2025 年 1 月，相关政策协调将取得进展，从而促进国际贸易和推广。

同时，公共和私人部门对农业基因组研究与开发的投资不断增加，加速了独特育种资源和先进基因分型系统的创建。领先的农业公司正大力投资加强其分子育种能力，以保护智慧财产权并获得竞争优势。例如，科迪华农业科技公司（Corteva AgriScience）在2025年初报告称，其2024财年的年度研发支出达到14.02亿美元，凸显了支持这项创新的资金规模。这些投资也正在产生商业性效益；先正达集团（Syngenta Group）在2025年3月宣布，其种子部门的全年销售额将达到48亿美元，证实了全球对先进种子产品的强劲需求。

市场挑战

全球分子育种市场的成长受到国际各地区复杂且分散的法律规范的严重阻碍。这种监管缺乏协调性为育种公司带来了巨大的不确定性，因为在一个国家利用分子育种技术开发的品种可能在出口市场遭到核准，或者需要进行昂贵且反覆的安全评估。这种不一致性迫使企业在错综复杂的合规要求中摸索前行，直接增加了研发成本，并延缓了改良动植物品种的市场推广。因此，与这些监管障碍相关的高额财务风险正在阻碍对新育种计划的投资，尤其是在那些难以承担高昂合规成本的小众作物领域。

近期行业统计数据凸显了这一障碍的严重性。根据国际种子联盟（ISF）2024年的一项调查，约33%的全球种子产业专业人士认为，建立可预测的、以科学为基础的监管体係是释放创新潜力的关键。这一数字表明，现有的监管壁垒构成了重大瓶颈，有效地阻碍了分子育种解决方案的规模化应用，并限制了商业性获取优良遗传性状的途径。

市场趋势

人工智慧驱动的预测育种模型正迅速成为全球分子育种市场的变革力量，重塑着遗传改良的实现方式。与依赖表型观察的传统选择技术不同，这些先进的计算系统能够处理海量基因组资料集，并高精度地预测性状结果。这优化了亲代选择，缩短了育种週期。这项技术进步正为采用精准育种的主要企业带来实质的商业性成果。例如，拜耳公司在2025年11月公布，其玉米种子及性状部门2025年第三季的销售额成长了22.4%。这一强劲的业绩归功于种植面积的扩大以及透过这些先进流程开发的高性能遗传资源的应用。

同时，市场正见证着分子技术应用从传统作物科学向水产养殖和畜牧业的显着扩张。这项转变的特点是基因组选择工具的广泛应用，旨在提高动物群体的抗病能力、饲料转换率和繁殖能力，这对于满足全球日益增长的蛋白质需求至关重要。领先的动物用药品公司近期的财务表现也印证了这一趋势的商业性可行性。根据硕腾公司（Zoetis）的数据显示，截至2025年11月，该公司2025年第三季畜牧业的有机营业收入达7.25亿美元，较去年同期成长10%。这表明，企业越来越依赖先进的遗传学和健康解决方案来提高生产力。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球分子育种市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 标记特异性方法（简单重复序列、单核苷酸多态性、表现序列标籤等）
  • 按用途（植物、牲畜）
  • 基于过程的选择（标记辅助选择、QTL定位、标记辅助回交）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美分子育种市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲分子育种市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区分子育种市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲分子育种市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲分子育种市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球分子育种市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Eurofins Scientific SE
• GC Group
• Illumina Inc.
• SGS SA
• Thermo-Fisher Scientific Inc.
• Intertek Group plc
• LemnaTec GmbH
• Charles River Laboratories International Inc.
• Bayer AG
• Slipstream Solutions

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Molecular Breeding Market is projected to expand from USD 7.79 Billion in 2025 to USD 12.37 Billion by 2031, reflecting a compound annual growth rate of 8.01%. This sector focuses on utilizing molecular biology techniques, particularly DNA markers, to identify plants or animals possessing specific genetic advantages like disease resistance or enhanced yield without necessarily using genetic modification. By enabling the identification of genes without waiting for phenotypic expression, this approach significantly hastens the breeding timeline. The market is primarily propelled by the intensifying global need for high-quality food supplies and the critical demand for crops capable of withstanding climate instability, which represents a fundamental, long-term requirement for agricultural sustainability rather than a fleeting market trend.

However, the expansion of this market is obstructed by complicated and disjointed regulatory systems across various nations. Divergent policies concerning breeding technologies create significant compliance obstacles that can postpone the market entry of enhanced varieties. Data from the International Seed Federation in 2024 highlights this issue, noting that nearly 75% of seed industry experts warned that inconsistent or unscientific regulations jeopardize the sector's ability to ensure global food security. Such regulatory unpredictability hinders the international exchange of genetic materials and fosters a challenging climate for research funding, potentially retarding the uptake of molecular breeding advancements.

Market Driver

The incorporation of CRISPR-Cas9 and sophisticated gene-editing instruments is transforming the Global Molecular Breeding Market by facilitating exact genetic adjustments that do not require foreign DNA integration. This technological evolution empowers breeders to generate high-yielding, climate-resilient crops much faster than traditional techniques, effectively skipping the prolonged backcrossing stages previously needed. Regulatory environments are increasingly accepting these advancements, often classifying gene-edited crops similarly to conventionally bred ones, which reduces compliance costs and barriers to entry. According to Euroseeds, by January 2025, nearly 300 regulatory rulings had affirmed the conventional classification of New Genomic Technique (NGT) plants worldwide by the end of 2024, indicating a policy harmonization that promotes international trade and adoption.

Simultaneously, increased public and private investment in agrogenomic research and development is accelerating the creation of proprietary germplasm and cutting-edge genotyping systems. Major agricultural entities are dedicating significant funds to enhance their molecular breeding capabilities to protect intellectual property and gain a competitive edge. For example, Corteva Agriscience reported in early 2025 that its annual R&D expenditures for 2024 reached $1.402 billion, highlighting the magnitude of financial dedication fueling this innovation. These investments are yielding commercial results, as demonstrated by Syngenta Group in March 2025, when its Seeds unit reported full-year sales of $4.8 billion, confirming strong global demand for advanced seed products.

Market Challenge

The growth of the Global Molecular Breeding Market is severely hindered by intricate and fragmented regulatory structures across various international regions. This lack of regulatory harmony generates considerable uncertainty for breeding firms, as varieties created with molecular tools in one nation might face denial or demand expensive, repetitive safety evaluations in export markets. Such inconsistency compels organizations to maneuver through a complex maze of compliance mandates, directly inflating research and development expenses while delaying the launch of improved animal and crop varieties. Consequently, the elevated financial risks linked to these regulatory obstacles deter investment in novel breeding initiatives, especially for niche crops that cannot sustain high compliance costs.

Recent industry statistics illustrate the gravity of this impediment. As per the International Seed Federation in 2024, roughly 33% of global seed sector experts pinpointed the establishment of predictable, science-based regulations as the most essential requirement for unleashing innovation. This figure emphasizes that existing regulatory obstructions serve as a major bottleneck, effectively pausing the industry's capacity to expand molecular breeding solutions and restricting the commercial accessibility of superior genetic traits.

Market Trends

The implementation of AI-powered predictive breeding models is fast becoming a game-changing trend in the Global Molecular Breeding Market, reshaping how genetic improvements are achieved. In contrast to conventional selection techniques dependent on phenotypic observation, these sophisticated computational systems process immense genomic datasets to forecast trait outcomes with great precision, thereby refining parental selection and condensing development timelines. This technological evolution is driving tangible commercial results for leading agriscience companies that have adopted precision breeding. For instance, Bayer reported in November 2025 that sales in its Corn Seed & Traits division rose by 22.4% during the third quarter of 2025, a strong performance attributed to expanded planting areas and the adoption of high-performance germplasm created via these advanced pipelines.

Concurrently, the market is observing a notable broadening of molecular applications into aquaculture and livestock, extending beyond its traditional focus on crop science. This shift is marked by the increasing utilization of genomic selection instruments to improve disease resistance, feed efficiency, and reproductive qualities in animal populations, which is vital for satisfying the rising global protein demand. The commercial feasibility of this trend is highlighted by recent financial outcomes from major animal health firms. According to Zoetis, in November 2025, the company realized a 10% increase in organic operational revenue for livestock in the third quarter of 2025, totaling $725 million, demonstrating the growing dependence of swine and cattle producers on advanced genetic and health solutions to optimize productivity.

Key Market Players

• Eurofins Scientific SE
• GC Group
• Illumina Inc.
• SGS SA
• Thermo-Fisher Scientific Inc.
• Intertek Group plc
• LemnaTec GmbH
• Charles River Laboratories International Inc.
• Bayer AG
• Slipstream Solutions

Report Scope

In this report, the Global Molecular Breeding Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Molecular Breeding Market, By Marker

• Simple Sequence Repeat
• Single Nucleotide Polymorphism
• Expressed Sequence Tags
• Others

Molecular Breeding Market, By Application

• Plant
• Livestock

Molecular Breeding Market, By Process

• Marker Assisted Selection
• QTL Mapping
• Marker assisted back crossing

Molecular Breeding Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Molecular Breeding Market.

Available Customizations:

Global Molecular Breeding Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Molecular Breeding Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Marker (Simple Sequence Repeat, Single Nucleotide Polymorphism, Expressed Sequence Tags, Others)
  • 5.2.2. By Application (Plant, Livestock)
  • 5.2.3. By Process (Marker Assisted Selection, QTL Mapping, Marker assisted back crossing)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Molecular Breeding Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Marker
  • 6.2.2. By Application
  • 6.2.3. By Process
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Molecular Breeding Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Marker
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Process
  • 6.3.2. Canada Molecular Breeding Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Marker
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Process
  • 6.3.3. Mexico Molecular Breeding Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Marker
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Process

7. Europe Molecular Breeding Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Marker
  • 7.2.2. By Application
  • 7.2.3. By Process
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Molecular Breeding Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Marker
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Process
  • 7.3.2. France Molecular Breeding Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Marker
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Process
  • 7.3.3. United Kingdom Molecular Breeding Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Marker
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Process
  • 7.3.4. Italy Molecular Breeding Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Marker
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Process
  • 7.3.5. Spain Molecular Breeding Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Marker
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Process

8. Asia Pacific Molecular Breeding Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Marker
  • 8.2.2. By Application
  • 8.2.3. By Process
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Molecular Breeding Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Marker
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Process
  • 8.3.2. India Molecular Breeding Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Marker
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Process
  • 8.3.3. Japan Molecular Breeding Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Marker
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Process
  • 8.3.4. South Korea Molecular Breeding Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Marker
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Process
  • 8.3.5. Australia Molecular Breeding Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Marker
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Process

9. Middle East & Africa Molecular Breeding Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Marker
  • 9.2.2. By Application
  • 9.2.3. By Process
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Molecular Breeding Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Marker
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Process
  • 9.3.2. UAE Molecular Breeding Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Marker
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Process
  • 9.3.3. South Africa Molecular Breeding Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Marker
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Process

10. South America Molecular Breeding Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Marker
  • 10.2.2. By Application
  • 10.2.3. By Process
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Molecular Breeding Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Marker
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Process
  • 10.3.2. Colombia Molecular Breeding Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Marker
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Process
  • 10.3.3. Argentina Molecular Breeding Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Marker
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Process

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Molecular Breeding Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Eurofins Scientific SE
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. GC Group
• 15.3. Illumina Inc.
• 15.4. SGS SA
• 15.5. Thermo-Fisher Scientific Inc.
• 15.6. Intertek Group plc
• 15.7. LemnaTec GmbH
• 15.8. Charles River Laboratories International Inc.
• 15.9. Bayer AG
• 15.10. Slipstream Solutions

16. Strategic Recommendations

17. About Us & Disclaimer